Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;28(1):61-71.
doi: 10.1016/j.berh.2014.01.007.

Biomarkers for osteoarthritis: current position and steps towards further validation

David J Hunter  1 , Michael Nevitt  2 , Elena Losina  3 , Virginia Kraus  4
Affiliations
Review

Biomarkers for osteoarthritis: current position and steps towards further validation

David J Hunter et al. Best Pract Res Clin Rheumatol. 2014 Feb.

Abstract

Historically disease knowledge development and treatment innovation in osteoarthritis (OA) has been considered to be slow. One of the many reasons purported as responsible for this slow pace has been the alleged lack of valid and responsive biomarkers to ascertain efficacy, which itself has been dependent upon the slow evolution of the understanding of the complex nature of joint tissue biology. This narrative review outlines the rationale for why we need OA biomarkers with regard to biomarker validation and qualification. The main biomarkers in current development for OA are biochemical and imaging markers. We describe an approach to biomarker validation and qualification for OA clinical trials that has recently commenced with the Foundation of NIH OA Biomarkers Consortium study cosponsored by the Osteoarthritis Research Society International (OARSI). With this approach we endeavor to identify, develop, and qualify biological markers (biomarkers) to support new drug development, preventive medicine, and medical diagnostics for osteoarthritis.

Keywords: Biomarkers; Osteoarthritis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Prevalence of disabilities and associated health conditions among adults--United States, 1999 [erratum appears in MMWR Morb Mortal Wkly Rep 2001 Mar 2;50(8):149] MMWR - Morbidity & Mortality Weekly Report. 2001;50:120–125. - PubMed
    1. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. American Journal of Public Health. 1994;84:351–358. - PMC - PubMed
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2197–2223. - PubMed
    1. Painful Realities. Access Economics, Arthritis Australia. 2007. The economic impact of Arthritis in Australia in 2007.
    1. Losina E, Weinstein AM, Reichmann WM, Burbine SA, Solomon DH, Daigle ME, et al. Lifetime risk and age of diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken ) 2012 - PMC - PubMed

Publication types